Eyconis is a clinical-stage biotechnology company advancing next-generation, long-acting ophthalmic therapeutics, focusing on improving vision for people with serious eye diseases such as wet age-related macular degeneration
Eyconis is a clinical-stage biotechnology company advancing next-generation, long-acting ophthalmic therapeutics, focusing on improving vision for people with serious eye diseases such as wet age-related macular degeneration.